INTC vs TMO: Which Is the Better Buy?
Side-by-side comparison of Intel Corporation and Thermo Fisher Scientific Inc. β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Intel Corporation Β· Technology
$133.99
-5.2% upside to fair value
Grade D
VS
Thermo Fisher Scientific Inc. Β· Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
INTC |
TMO |
| Current Price |
$133.99 |
$464.61 |
| Fair Value Estimate |
$126.97 |
$498.27 |
| Upside to Fair Value |
-5.2%
|
+7.2%
|
| Market Cap |
$673.4B |
$172.7B |
| Forward P/E |
-216.1x
|
25.2x
|
| EV / EBITDA |
61.5x
|
19.1x
|
| Price / Sales |
12.5x
|
3.8x
|
| Price / FCF |
-215.9x
|
25.6x
|
| Revenue Growth YoY |
+7.2%
|
+6.2%
|
| Gross Margin |
35.4%
|
39.4%
|
| Operating Margin |
-9.4%
|
17.8%
|
| Return on Equity |
-3.0%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
β
|
3.91%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Intel Corporation is a leading semiconductor company operating primarily in the technology sector with a focus on semiconductors. The business quality is currently challenged due to negative earnings growth of 354.1% in the most recent quarter and negative profitability metrics including a net margin of -5.9% and operating margin of -9.4%. Despite a sizable market cap of $1678.9 billion and revenβ¦
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. β¦
Accumulation Zones
| Metric |
INTC |
TMO |
| Zone Low |
$95.23 |
$373.70 |
| Zone High |
$107.92 |
$423.53 |
| In Buy Zone? |
No
|
No
|